Page 120 - Abt News Today

WealthPlan Investment Management LLC lessened its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 44.4% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 93,093 shares of the healthcare product maker’s stock after selling 74,382 shares during the quarter. Abbott Laboratories makes up approximately 1.6% of WealthPlan Investment Management LLC’s investment […]

Public Employees Retirement Association of Colorado lowered its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 4.2% in the first quarter, according to the company in its most recent filing with the SEC. The firm owned 1,289,212 shares of the healthcare product maker’s stock after selling 55,986 shares during the quarter. Public […]

Wrapmanager Inc. lessened its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 2.1% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 20,399 shares of the healthcare product maker’s stock after selling 442 shares during the quarter. […]

Alpine Woods Capital Investors LLC cut its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 21.0% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 15,579 shares of the healthcare product maker’s stock after selling 4,130 shares during the quarter. Alpine Woods […]

Cannell & Co. trimmed its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 0.8% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 329,739 shares of the healthcare product maker’s stock after selling 2,677 shares during the quarter. Abbott Laboratories makes […]

Beaumont Financial Advisors LLC trimmed its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 2.1% during the first quarter, HoldingsChannel reports. The firm owned 73,005 shares of the healthcare product maker’s stock after selling 1,589 shares during the quarter. Beaumont Financial Advisors LLC’s holdings in Abbott Laboratories were worth $7,393,000 at the […]

Abbott Laboratories (NYSE:ABT – Get Free Report) and Enliven Therapeutics (NASDAQ:ELVN – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, analyst recommendations and earnings. Institutional and Insider Ownership 73.1% of Abbott Laboratories […]

ProVise Management Group LLC cut its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 2.0% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,066 shares of the healthcare product maker’s stock after selling 106 shares during the quarter. […]

VELA Investment Management LLC boosted its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 5.5% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 24,073 shares of the healthcare product maker’s stock after buying an additional 1,245 shares during the quarter. Abbott […]

Atlantic Union Bankshares Corp lessened its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 5.9% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 99,169 shares of the healthcare product maker’s stock after selling 6,198 shares during the quarter. Abbott Laboratories […]